• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部恶性肿瘤患者术后静脉血栓栓塞症的临床分析

[Clinical analysis of head and neck malignant tumor patients with postoperative venous thromboembolism].

作者信息

Xiao Jian, Song Yexun, Tan Guolin

机构信息

Department of Otolaryngology Head and Neck Surgery,Third Xiangya Hospital of Central South University,Changsha,410013,China.

出版信息

Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2021 Sep;35(9):779-783. doi: 10.13201/j.issn.2096-7993.2021.09.003.

DOI:10.13201/j.issn.2096-7993.2021.09.003
PMID:34628828
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10127835/
Abstract

To investigate the incidence, risk factors, prevention and treatment of venous thromboembolism(VTE) after head and neck malignant tumor surgery. From February 2014 to February 2020, a total of 889 patients with head and neck malignant tumor treated in the Department of Otolaryngology Head and Neck Surgery of the Third Xiangya Hospital of Central South University were selected as the research objects. 16 patients with VTE were selected as the observation group, and 30 patients were randomly selected as the control group from 873 patients without VTE. The related evaluation indexes were analyzed by univariate and multivariate logistic regression. ①VTE occurred in 16 cases of 889 patients with head and neck malignancy, and the incidence of VET in head and neck malignant tumor patients was 1.80%. ② Univariate analysis showed that postoperative VTE was related to gender, age, BMI, preoperative PICC, operation time and bed rest time. Multivariate logistic regression analysis indicated that age≥60 years old(=0.087, 95%: 0.012-0.643), preoperative PICC(=0.133, 95% 0.021-0.856) and operation time≥3 h(0.119, 95% 0.016-0.889) was an independent risk factor of VTE after head and neck malignant tumor operation (<0.05). VTE is a serious complication after operation for head and neck malignant tumor. The risk factors of postoperative VTE include age≥60 years, preoperative PICC and operation time≥3 h. Early prevention and timely treatment are the key to reduce postoperative VTE mortality.

摘要

探讨头颈部恶性肿瘤手术后静脉血栓栓塞症(VTE)的发生率、危险因素、预防及治疗方法。选取2014年2月至2020年2月在中南大学湘雅三医院耳鼻咽喉头颈外科治疗的889例头颈部恶性肿瘤患者作为研究对象。选取16例发生VTE的患者作为观察组,从873例未发生VTE的患者中随机选取30例作为对照组。采用单因素和多因素logistic回归分析相关评估指标。①889例头颈部恶性肿瘤患者中,16例发生VTE,头颈部恶性肿瘤患者VET发生率为1.80%。②单因素分析显示,术后VTE与性别、年龄、BMI、术前PICC、手术时间及卧床时间有关。多因素logistic回归分析表明,年龄≥60岁(=0.087,95%:0.012 - 0.643)、术前PICC(=0.133,95% 0.021 - 0.856)及手术时间≥3 h(0.119,95% 0.016 - 0.889)是头颈部恶性肿瘤手术后VTE的独立危险因素(<0.05)。VTE是头颈部恶性肿瘤手术后的严重并发症。术后VTE的危险因素包括年龄≥60岁、术前PICC及手术时间≥3 h。早期预防和及时治疗是降低术后VTE死亡率的关键。

相似文献

1
[Clinical analysis of head and neck malignant tumor patients with postoperative venous thromboembolism].头颈部恶性肿瘤患者术后静脉血栓栓塞症的临床分析
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2021 Sep;35(9):779-783. doi: 10.13201/j.issn.2096-7993.2021.09.003.
2
[Analysis of Influencing Factors for Postoperative Venous Thromboembolism 
of Thymic Malignancies].[胸腺恶性肿瘤术后静脉血栓栓塞症的影响因素分析]
Zhongguo Fei Ai Za Zhi. 2021 Jul 20;24(7):497-502. doi: 10.3779/j.issn.1009-3419.2021.101.22. Epub 2021 Jun 17.
3
Venous thromboembolism incidence in head and neck surgery patients: Analysis of the Veterans Affairs Surgical Quality Improvement Program (VASQIP) database.头颈部手术患者静脉血栓栓塞发生率:退伍军人事务部手术质量改进计划(VASQIP)数据库分析。
Oral Oncol. 2018 Feb;77:22-28. doi: 10.1016/j.oraloncology.2017.12.002. Epub 2017 Dec 16.
4
Prospective study of venous thromboembolism in patients with head and neck cancer after surgery.头颈部癌症患者手术后静脉血栓栓塞的前瞻性研究。
JAMA Otolaryngol Head Neck Surg. 2013 Nov;139(11):1143-50. doi: 10.1001/jamaoto.2013.4911.
5
[Risk Factors Associated with Venous Thromboembolism after Lung Cancer Surgery: A Single-center Study].[肺癌手术后静脉血栓栓塞的相关危险因素:一项单中心研究]
Zhongguo Fei Ai Za Zhi. 2018 Oct 20;21(10):753-760. doi: 10.3779/j.issn.1009-3419.2018.10.04.
6
Venous Thromboembolism Risk in Head and Neck Cancer: Significance of the Preoperative Platelet-to-Lymphocyte Ratio.头颈部癌症中的静脉血栓栓塞风险:血小板与淋巴细胞比值的意义。
Otolaryngol Head Neck Surg. 2018 Jul;159(1):85-91. doi: 10.1177/0194599818756851. Epub 2018 Feb 6.
7
[Analysis of incidence and risk factors for postoperative venous thromboembolism in patients with stageⅠ a non-small-cell lung cancer].[Ⅰa期非小细胞肺癌患者术后静脉血栓栓塞症的发生率及危险因素分析]
Zhonghua Yi Xue Za Zhi. 2021 Nov 9;101(41):3417-3421. doi: 10.3760/cma.j.cn112137-20210418-00929.
8
Prevalence and Risk Factors for the Development of Venous Thromboembolism After Spinal Tumor Surgery.脊柱肿瘤手术后静脉血栓栓塞症的发生率及危险因素。
World Neurosurg. 2022 Aug;164:e177-e182. doi: 10.1016/j.wneu.2022.04.064. Epub 2022 Apr 21.
9
Venous thromboembolism in patients with head and neck cancer after surgery.头颈部癌症患者手术后的静脉血栓栓塞症。
Head Neck. 2013 Jan;35(1):4-9. doi: 10.1002/hed.22920. Epub 2012 Feb 2.
10
Justification of routine venous thromboembolism prophylaxis in head and neck cancer reconstructive surgery.头颈部癌症重建手术中常规静脉血栓栓塞预防的理由。
Head Neck. 2017 Dec;39(12):2450-2458. doi: 10.1002/hed.24914. Epub 2017 Sep 30.

本文引用的文献

1
Prediction and Prevention of Cancer-Associated Thromboembolism.癌症相关血栓栓塞的预测与预防。
Oncologist. 2021 Jan;26(1):e2-e7. doi: 10.1002/onco.13569. Epub 2020 Dec 4.
2
Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis.直接口服抗凝剂治疗癌症相关静脉血栓栓塞症:系统评价和荟萃分析。
Blood. 2020 Sep 17;136(12):1433-1441. doi: 10.1182/blood.2020005819.
3
Cancer-Associated Thrombosis: A Two-Way Street.癌症相关血栓形成:双向之路。
Semin Thromb Hemost. 2019 Sep;45(6):559-568. doi: 10.1055/s-0039-1693472. Epub 2019 Aug 5.
4
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update.静脉血栓栓塞症预防和治疗癌症患者:ASCO 临床实践指南更新。
J Clin Oncol. 2020 Feb 10;38(5):496-520. doi: 10.1200/JCO.19.01461. Epub 2019 Aug 5.
5
Analysis of risk factors for deep venous thrombosis in patients with gynecological malignant tumor: A clinical study.妇科恶性肿瘤患者深静脉血栓形成的危险因素分析:一项临床研究
Pak J Med Sci. 2019 Jan-Feb;35(1):195-199. doi: 10.12669/pjms.35.1.365.
6
Cancer-Associated Thrombosis: An Overview of Mechanisms, Risk Factors, and Treatment.癌症相关血栓形成:机制、危险因素及治疗概述
Cancers (Basel). 2018 Oct 11;10(10):380. doi: 10.3390/cancers10100380.
7
Antithrombotic Therapy for Venous Thromboembolism and Prevention of Thrombosis in Otolaryngology-Head and Neck Surgery: State of the Art Review.耳鼻喉头颈外科学中静脉血栓栓塞症的抗栓治疗与血栓预防:最新综述。
Otolaryngol Head Neck Surg. 2018 Apr;158(4):627-636. doi: 10.1177/0194599818756599. Epub 2018 Feb 27.
8
Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative Neoplasms: A Population-Based Cohort Study.骨髓增殖性肿瘤患者的动脉和静脉血栓形成风险:一项基于人群的队列研究。
Ann Intern Med. 2018 Mar 6;168(5):317-325. doi: 10.7326/M17-0028. Epub 2018 Jan 16.
9
Cancer and Venous Thromboembolic Disease: A Review.癌症与静脉血栓栓塞性疾病:综述
Oncologist. 2017 Feb;22(2):199-207. doi: 10.1634/theoncologist.2016-0214. Epub 2017 Feb 7.
10
[Chinese expert consensus on the diagnosis and management of acute pulmonary embolism (2015)].《急性肺栓塞诊断与治疗中国专家共识(2015版)》
Zhonghua Xin Xue Guan Bing Za Zhi. 2016 Mar;44(3):197-211. doi: 10.3760/cma.j.issn.0253-3758.2016.03.005.